Fulgent Genetics, Inc. (FLGT) › Cash & EquivalentsFulgent Genetics, Inc. (FLGT) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2015-12-31: $489.0K2016-12-31: $7.90M2017-12-31: $6.49M2018-12-31: $6.74M2019-12-31: $11.96M2020-12-31: $87.43M2021-12-31: $164.89M2022-12-31: $79.51M2023-12-31: $97.47M2024-12-31: $55.14M2025-12-31: $50.19M$50.19M2015-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$50.19M-9.0%2026-02-27Balance as of period end2024-12-31$55.14M-43.4%2026-02-27Balance as of period end2023-12-31$97.47M+22.6%2026-02-27Balance as of period end2022-12-31$79.51M-51.8%2025-02-28Balance as of period end2021-12-31$164.89M+88.6%2023-02-28Balance as of period end2020-12-31$87.43M+630.7%2022-02-28Balance as of period end2019-12-31$11.96M+77.6%2021-03-08Balance as of period end2018-12-31$6.74M+3.8%2020-03-13Balance as of period end2017-12-31$6.49M-17.8%2019-03-22Balance as of period end2016-12-31$7.90M+1514.9%2018-03-20Balance as of period end2015-12-31$489.0K—2017-03-17Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)